Shree Ganesh Bio-Tech (India) Limited (BOM:539470)
India · Delayed Price · Currency is INR 0.8300
0.00 (0.00%)
At close: Jul 15, 2025
BOM:539470 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.13 | 4.28 | 4.8 | 0.35 | 0.24 | Upgrade |
Short-Term Investments | 91.5 | - | - | - | - | Upgrade |
Cash & Short-Term Investments | 91.63 | 4.28 | 4.8 | 0.35 | 0.24 | Upgrade |
Cash Growth | 2040.91% | -10.85% | 1263.92% | 45.54% | 35.44% | Upgrade |
Accounts Receivable | - | 33.03 | 193.29 | 438.91 | 283.39 | Upgrade |
Receivables | - | 33.03 | 193.29 | 438.91 | 283.39 | Upgrade |
Inventory | 28.9 | - | - | - | - | Upgrade |
Other Current Assets | 4.92 | 0 | 0.33 | 0.42 | 0.42 | Upgrade |
Total Current Assets | 125.45 | 37.31 | 198.42 | 439.68 | 284.05 | Upgrade |
Property, Plant & Equipment | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 | Upgrade |
Long-Term Investments | - | - | - | 32.2 | 30.6 | Upgrade |
Other Long-Term Assets | 0 | -0 | 0 | - | - | Upgrade |
Total Assets | 634.88 | 736.22 | 795.23 | 935.54 | 746.27 | Upgrade |
Accounts Payable | - | 103.6 | 164.9 | 323.09 | 165.28 | Upgrade |
Accrued Expenses | - | - | 0 | 0 | 0 | Upgrade |
Current Income Taxes Payable | 1.09 | 2.34 | 6.76 | 9.27 | 1.11 | Upgrade |
Other Current Liabilities | 1.23 | 0.5 | 0 | -0 | 0.05 | Upgrade |
Total Current Liabilities | 2.32 | 106.44 | 171.66 | 332.36 | 166.45 | Upgrade |
Long-Term Debt | - | - | - | - | 1.9 | Upgrade |
Other Long-Term Liabilities | - | -0 | - | 0 | - | Upgrade |
Total Liabilities | 2.32 | 106.44 | 171.66 | 332.36 | 168.35 | Upgrade |
Common Stock | 398.62 | 398.62 | 398.62 | 199.31 | 199.31 | Upgrade |
Additional Paid-In Capital | - | 54.33 | 54.33 | 253.64 | 253.64 | Upgrade |
Retained Earnings | - | 176.82 | 170.62 | 150.23 | 124.97 | Upgrade |
Comprehensive Income & Other | 233.94 | - | - | - | - | Upgrade |
Shareholders' Equity | 632.56 | 629.78 | 623.57 | 603.18 | 577.92 | Upgrade |
Total Liabilities & Equity | 634.88 | 736.22 | 795.23 | 935.54 | 746.27 | Upgrade |
Total Debt | - | - | - | - | 1.9 | Upgrade |
Net Cash (Debt) | 91.63 | 4.28 | 4.8 | 0.35 | -1.66 | Upgrade |
Net Cash Growth | 2040.91% | -10.85% | 1263.92% | - | - | Upgrade |
Net Cash Per Share | 0.33 | 0.01 | 0.01 | 0.00 | -0.00 | Upgrade |
Filing Date Shares Outstanding | 473 | 398.62 | 398.62 | 398.62 | 398.62 | Upgrade |
Total Common Shares Outstanding | 473 | 398.62 | 398.62 | 398.62 | 398.62 | Upgrade |
Working Capital | 123.13 | -69.13 | 26.75 | 107.31 | 117.6 | Upgrade |
Book Value Per Share | 1.34 | 1.58 | 1.56 | 1.51 | 1.45 | Upgrade |
Tangible Book Value | 632.56 | 629.78 | 623.57 | 603.18 | 577.92 | Upgrade |
Tangible Book Value Per Share | 1.34 | 1.58 | 1.56 | 1.51 | 1.45 | Upgrade |
Machinery | - | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.